chrisvoncsefalvay/vaers-outcomes huggingface dataset:
After 1st dose intense pain in right foot and knee overall joint pain.; After 1st dose intense pain in right foot and knee overall joint pain.; This is a spontaneous report from a contactable consumer (patient). This 72-year-old male consumer received the first single dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), on 25Feb2021, in right arm, for COVID-19 immunisation. Medical history included mild preexisting shoulder issue. Covid prior vaccination: no. Covid tested post vaccination: no. Known allergies: no. Concomitant medications were not reported. After the first dose, on 26Feb2021, the patient experienced intense pain in right foot and knee overall joint pain. No treatment was received. The patient subsequently received the second dose of vaccine on 18Mar2021 at 13:00 in right arm. After the second dose pain intensified and spread to hands wrists and shoulders. Very limited mobility with intense pain. Both shoulders very intense pain even with NSAIDS. Without NSAIDS original pains returned until taking naproxen 500 mg or similar. Continuing with no improvement. The patient had mild preexisting shoulder issue but not pain and full mobility. He believed there was a genetic autoimmune issue. But these intense symptoms were directly resulting from both vaccinations. The events resulted in disability or permanent damage and had not yet resolved. Information on the lot/batch number has been requested.; Sender's Comments: Linked Report(s): same patient, different drug dose/event
Tired, weak, mild muscle ache (besides significant pain at site of injection). So far lasting >1 day
PT states on 1/18/03 her arm started itching and became red / swollen at inject site. Had gotten worse each day until coming to clinic on 1/20/03. PT advised to use warm compression and an andgesic(?) such as Tylenol. PT states it was a total of 10 days before area was completely clean.
Patient/ stated he was "lightheaded".  Patient laid on floor and asked to elevate legs on chairs.  BP 180/20, pulse 80, respirations 16.  Patient recovered on own with some water, rest (laying down), and a snack.  Patient transported home by mother once stable.
Appears to be peripheral and sensory neuropathy.; Appears to be peripheral and sensory neuropathy.; Woke up in middle of night with numbness and tingling and discomfort in both feet; Woke up in middle of night with numbness and tingling and discomfort in both feet; Woke up in middle of night with numbness and tingling and discomfort in both feet; touch sensitivity; This is a spontaneous report from a  contactable  nurse.    A 77-years-old patient of an unspecified gender  received the first dose of  bnt162b2 (BNT162B2; Lot # EL9266), via an unspecified route of administration in the left arm on 18Feb2021 08:00 at single dose for covid-19 immunisation .  Medical history included atrial fibrillation , supraventricular tachycardia,  gastrooesophageal reflux disease  , ocular myasthenia , arthritis (2 joint eplacements) , hiatus hernia  , glucose tolerance impaired.  Concomitant medication included apixaban (ELIQUIS), flecainide (FLECAINIDE), metoprolol tartrate (METOPROLOL TARTRATE), atorvastatin (LIPITOR [ATORVASTATIN]), estradiol (ESTRADIOL).  The patient previously took cortisone and experienced rash, zocor and experienced myalgia, erythromycin and experienced vomiting, augmentin  and experienced vomiting.  The patient  stated that woke up in middle of night with numbness and tingling and discomfort in both feet. Progressing (hands,legs,back) better in day but wake up at night. No diagnosis yet. Appears to be peripheral and sensory neuropathy. Hearing sensitivity, touch sensitivity. The events onset is 19Feb2021 01:00 the outcome is not recovered. The event peripheral neuropathy is an always serious event.  Further information has been requested.; Sender's Comments: Based on available information, a possible contributory role of the subject product, BNT162B2 vaccine, cannot be excluded for the reported events of peripheral and sensory neuropathy and other events due to temporal relationship.  There is limited information provided in this report.  Additional information is needed to better assess the case, including complete medical history, diagnostics including nerve conduction tests, counteractive treatment measures and concomitant medications. This case will be reassessed once additional information is available.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
Onset: 3 days post vaccine.  Nausea, vomiting, diarrhea.  Headache,  mild fever.
My period was late and only 1 day long, normally 5 days long.; This is a spontaneous report from a contactable consumer, the patient. A 20-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on an unknown date in Apr2021 at 16:15 (at the age of 20-years-old) as a single dose for COVID-19 immunisation. Medical history included anxiety. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included escitalopram oxalate (LEXAPRO) and ethinylestradiol / norethisterone acetate (JUNEL) for unknown indication from unknown date and unknown if ongoing. On 29Apr2021, the patient's period was late and only 1 day long, normally 5 days long. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the event. Since the vaccination, it was unknown whether the patient had been tested for COVID-19. The clinical outcome of the event period was late and only 1 day long, normally 5 days long was unknown at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Withing 10 minutes of vaccination client reported difficulty breathing, swelling of mouth, tongue, esophagus. Sometime later the client reported having a severe reaction when she ate frosting that had egg in it. Client reported having 5 Emergency room visits.
This spontaneous report as received from a physician via company representative refers to a patient of unknown age and gender. The patient's pertinent medical history, current conditions and concomitant medications were not reported. No drug reactions or allergies were reported. On an unknown date the patient was vaccinated with M-M-R II (dosing details were not reported). On an unknown date the patient experienced rash and had to go to ER (emergency room). The patient sought medical attention. The outcome of the event rash was not reported. The reported did not provided the causality assessment between the event and the suspect therapy. There was no product quality complaint involved. Additional information has been requested.
Pt complained of a 3 weeks hx of left calf pain after running.  Pt had also had a cross country flight.  Dx with left LE DVT.  Pt on coumadin and lovenox til 4/20/04.  6/07 pt experienced left calf pain and pain dorsum of left foot for about 5 weeks prior to a flight and a one week cruise.  Upon return the pt went to the hospital and it was determined that he had a left foot superficial venous thrombosis.  3/17/08 pt was treated in ER for palpitations.  Pt had an IV.  Upper Ext Venous Duplex which showed superficial venous thrombosis.  Pt wonders if this is caused by AVA?  Symptoms: Muscle Pain, Muscle Pain, Muscle Pain.
14 days after booster shot, developed dermatographic urticaria. After visit with PCP and Allergist, found that methylprednisolone did not alleviate symptoms, however high doses of zyrtec/claritin were successful at eliminating urticaria. Famotidine was used early on but was unclear if it improved symptoms. Redness remained regardless of drug/dose. Over the course of 7 weeks, I was able to slowly taper off antihistamines. Initially took 1 dose claritin in AM and 1 dose zyrtec in PM with benadryl for breakthrough urticaria. At 7 weeks, stopped antihistamines and symptoms have returned but with less severity.  Per support groups online, may have to suffer through symptoms for a while longer before they subside, but it feels good to not be drowsy all the time after getting off antihistamines.
Patient under 18 years of age, got the Covid19 Vaccine Moderna; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Patient under 18 years of age, got the Covid19 Vaccine Moderna) in a 16-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Patient under 18 years of age, got the Covid19 Vaccine Moderna). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Patient under 18 years of age, got the Covid19 Vaccine Moderna) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported. No treatment medication was reported.
Lower lip swollen slightly the evening of the vaccination and remained the same until the morning of Saturday, January 16, when it was twice as swollen and firm to the touch. In the early afternoon, swelling has reduced by 25%. There is no problem with breathing, eating, speaking, numbness or itching.
Severe upper back and neck pain, numbness, muscle pain, soreness in left arm where the injection was placed.  Pain lasted for 5 days.  Currently experiencing muscle pain in upper left back.
I was diagnosed with a Central Retina Vein Occulsion or eye stoke (left eye) due to blood clot obstructing blood flow through central vein.
PT 30y female on site rec'd J&J vaccine @ 10:20AM to L arm. Went to observation and started to feel tingling and pain with itching to L arm at 10:30AM. RN assessed PT and notified NP. NP and PT was given 25mg of Benedryl @10:35am pt denies any SOB, face tightness, chest pain, claudication, arm weakness. NP @ site stated that PT stated that numbness and tingling  felt like it was improving , extremities warm to the touch , pulse present and bounding. Strength equal throughout upper extremities , no hives, rash, bruising noted @10:46am. PT  starts to c/o feeling a different type of pain to L arm it feels like scraping of my bone and I feel lightheaded. NP gave 0.3mg of Epi to LL thigh, EMS on site and Pt transported @ loss to hospital at this time pt stated that she has no one to pick up her car.
Painful arm (could not lift arm) for 2 days Cough  Fever  Body aches/chills Loss of smell/taste  Dizziness  Headache  Extreme fatigue  Neck pain  These symptoms lasted approximately 9 days
I received my 2nd dose of the Moderna vaccine on 5/4/2021. About a month later (early June 2021), I started experiencing symptoms I had when I received the first dose of the vaccine (4/6/2021) . Those symptoms include: dizziness (vertigo), brain fog, forehead pressure (near the sinuses), as well as hair loss. The symptoms ?flare up? 2-3 times a day, persist for 15 minutes to  2 hours, then go away. I have never experienced these symptoms prior to the first vaccination.   I let the symptoms persist for about a month until I went to my primary care physician (PCP) to see if she could understand what was wrong (early July 2021). Based on my symptoms, she believed it may have been a sinus infection, so she prescribed me a 10-day antibiotics course, which I completed, but to no avail. Throughout the following months, the symptoms persisted until I finally went to see an ENT doctor. I saw the ENT in early October 2021 - he didn't see anything wrong with my sinuses or my ears and sent me for a CT scan of the sinuses. The CT scan of the sinuses came out clear. He recommended I see a neurologist.  I set up an appointment to see a neurologist in November, but before that, around the weekend of 10/23/2021, I started experiencing pain and numbness (almost like local anesthesia at the dentist?s office) going down the left side of my body - from the left side of my temple to the arch of my left foot, and it went into the left arm as well. I was able to move my extremities. During this time I started having pressurized headaches near the temples as well, which caused eye pain. This persisted for a few days, until I finally went to the ER as the feeling of numbness was paired with shortness of breath (unclear if that was anxiety from the numbness or related). By the time I reached the ER, the numbness had mostly subsided. While in the ER, they took a CT scan of my brain and ran some blood tests - all were normal.  I saw the ophthalmologist on 11/3/201, and he said the pressure in my eyes were fine and didn?t see a problem with the optic nerve.  I saw the neurologist on 11/4/2021, where he assessed me in his office - he said I did fine on the assessment. He sent me for an MRI of the brain and for a blood test. The MRI of my brain came out normal, as did the blood test.   During the month, the numbness went down, but the pain persists, primarily in the left pectoral muscles, left arm and thumb.  With my symptoms starting back in June 2021 persisting along with these new symptoms, I went back to my PCP in early December 2021 to see if she could think of any other reason this could be happening. She sent me for another blood test to check for anemia as the neurologist covered everything else - it came back normal.  All of my symptoms persist.
Systemic - fever, chills (rigors), severe headache myalgias evening of vaccine with 16x15cm local redness, swelling, pain, tenderness, warmth. Pt felt ill with systemic sxs improving in last 24 hours. Onset 72 hours ago. Rx SOLU-MEDROL & TAMIFLU 25 bid x 5D. Will email picture of local reaction 12x16 cm urticarial patch.
Refridgeration excursions identified; No adverse event; Poor quality vaccine administered; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Refridgeration excursions identified), POOR QUALITY PRODUCT ADMINISTERED (Poor quality vaccine administered) and NO ADVERSE EVENT (No adverse event) in a 62-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7146B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 22-Sep-2022 at 11:30 AM, the patient received fourth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) .5 milliliter. On 22-Sep-2022 at 11:30 AM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Poor quality vaccine administered). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Refridgeration excursions identified) and NO ADVERSE EVENT (No adverse event). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Refridgeration excursions identified), POOR QUALITY PRODUCT ADMINISTERED (Poor quality vaccine administered) and NO ADVERSE EVENT (No adverse event) outcome was unknown. Not Provided      For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for PRODUCT TEMPERATURE EXCURSION ISSUE (Refridgeration excursions identified) and POOR QUALITY PRODUCT ADMINISTERED (Poor quality vaccine administered).    No concomitant products reported.  It was reported that refrigeration excursions identified, state vaccine was housed in these units. There were excursions noted. Manufactures were notified and the state department and made aware of the situation. The Nurse called for a clinic that she was assisting. The clinic had a similar issue with vaccines stored in their freezer. Vaccines stored in the refrigerator that underwent several temperature excursions going back to August 2022. Date vial moved from freezer to refrigerator was 07 Sep 2022. The vial underwent temperature excursion. The body site was mentioned as deltoid.  No adverse reactions reported for the patient.  No treatment products reported.
Inadvertent temperature excursion, vaccine stored in freezer beyond allowable two week excursion protocol per Pfizer, no concern for any other adverse events, recommended repeating dose
Dizziness; Red at the injection site; Pain at the injection site; Itching with a hard knotthe size of a quarter at the injection site; Diarrhea; This is a spontaneous report received from a contactable consumer, the patient. A 59-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown), via an unspecified route of administration in right arm on 18Mar2021 at 13:15 (at the age of 59-year-old), as a single dose for COVID-19 immunisation. Medical history included auto immune disease. Concomitant medications were not reported. The patient did not have any allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the vaccine. On 18Mar2021 at 22:00, the patient had red, pain and itching with a hard knot the size of a quarter at the injection site and she also experienced dizziness and diarrhea. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care visit. The clinical outcome of red at the injection site, pain at the injection site, itching at the injection site, dizziness and diarrhea was unknown at the time of this report. Information about lot number cannot be obtained. No further information is expected.
Side effects; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Side effects) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Side effects). At the time of the report, VACCINATION COMPLICATION (Side effects) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications reported.  No treatment information was provided.
Local reaction of left arm deltoid to elbow with redness and induration and FULL mobility and no pain.
Patient's headache started Friday morning after she got to school. I picked her up around 10 am.  Her headache got worse and worse throughout the day. She vomited 4 times. She has had 3-4 migraines in the last 3 years. At first I thought that was what this was, but after speaking to her, I discovered her symptoms were not the same as the other migraines. Her pain was in a different location and she did not have any eye sensitivity. Her pain has not gone away and today is day 4!
This spontaneous report was received from a certified medical assistant and refers to an unspecified number of patients of unknown age and gender. There was no information about the patients' concurrent conditions, concomitant therapies or medical histories provided. On unknown dates between 19-APR-2017 and 23-MAY-2017, the patients were vaccinated with improperly stored doses of ROTATEQ orally, lot # L042219 with expiration date 02-JUN-2019 and lot # M007311 with expiration date 30-NOV-2017 (dose was not reported). There was no adverse effect reported. Administered doses of vaccines experienced the temperature excursion between 32 and 35 degrees Fahrenheit for 24 hours. A Digital Data logger was not involved. There were no previous temperature excursions reported. This is one of several reports received from the same reporter.  Additional information has been requested.; Sender's Comments:  US-009507513-1705USA014464: US-009507513-1705USA014496: US-009507513-1705USA014494: US-009507513-1705USA014495:
This spontaneous report was received from a 53-year-old female patient who was reporting on herself. The patient did not have any pertinent medical history and known drug reactions or allergies. She declined to provide information concerning concomitant medications. On 06-JUN-2017, the patient was vaccinated with a dose of ZOSTAVAX injection (dose, route of administration, lot number and expiration date were not reported), for prevention of shingles. On the evening of 07-JUN-2017, she noticed that her arm was red at the injection site, had a hard lump and was tender to the touch. The patient did not receive treatment for the events. There was no lab diagnostic tests performed. At the time of this report, she did not report these events to her health provider. No product quality complaint (PQC) was involved. The outcome of the events and the relatedness between the events and ZOSTAVAX were not reported. Additional information has been requested.
Covid vaccine make your boobs grow; This spontaneous case was reported by a consumer and describes the occurrence of BREAST SWELLING (Covid vaccine make your boobs grow) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced BREAST SWELLING (Covid vaccine make your boobs grow). At the time of the report, BREAST SWELLING (Covid vaccine make your boobs grow) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       no treatment medication provided no concomitant medication provided
Developed itchy, painful and red sores - "similar to chicken pox" .  Patient called Dr and Dr told him that he was allergic to the Shingrix and not to get the 2nd dose.  The sores resolved on their own after two weeks.  Patient was not seen by the Dr and did not seek out or need further medical treatment.
Patient came in to receive 2nd booster.  had received 3 doses of Pfizer.  Pharmacist on duty recommended Moderna.  Pharmacist administered 0.5ml dose instead of the recommended 0.25ml dose.  Patient later complained of high fever >101, body aches fatigue and swelling in the armpit of the injection site arm
Localized erythematous rash around injection site, measuring 9.5 X 5.5cm, mildly tender, no fever no abscess.
Fever of over 101. Severe body aches (painful to touch skin). Headache. Nausea. All sx started 8 hours after receiving vaccine and lasted for 24 hours.